Free Trial
→ Why Trump’s “Smart Dollar” could rewrite the rules (From Stansberry Research) (Ad)tc pixel

Rafael (NYSE:RFL) Upgraded to "Hold" at Wall Street Zen

Written by MarketBeat
Updated August 14, 2025
Rafael logo with Medical background

Key Points

  • Rafael Holdings has been upgraded from a "sell" to a "hold" rating by analysts at Wall Street Zen.
  • CEO Howard S. Jonas purchased over 13 million shares at an average price of $1.28, significantly increasing his stake in the company.
  • Rafael reported a negative earnings per share of ($0.19) for the last quarter, with a revenue of $0.36 million.
  • Five stocks to consider instead of Rafael.

Rafael (NYSE:RFL - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a "sell" rating to a "hold" rating in a report released on Sunday.

Rafael Stock Down 1.8%

Rafael stock traded down $0.03 during mid-day trading on Friday, reaching $1.63. The company had a trading volume of 12,037 shares, compared to its average volume of 134,636. Rafael has a 52 week low of $1.28 and a 52 week high of $3.19. The company has a 50 day moving average of $1.90 and a 200-day moving average of $1.81. The firm has a market cap of $57.20 million, a price-to-earnings ratio of -1.73 and a beta of 0.99.

Rafael (NYSE:RFL - Get Free Report) last released its quarterly earnings data on Wednesday, June 11th. The company reported ($0.19) EPS for the quarter. The business had revenue of $0.36 million for the quarter. Rafael had a negative return on equity of 24.75% and a negative net margin of 3,127.60%.

Insider Activity

In related news, CEO Howard S. Jonas acquired 13,080,457 shares of the stock in a transaction on Thursday, June 5th. The stock was purchased at an average price of $1.28 per share, for a total transaction of $16,742,984.96. Following the transaction, the chief executive officer owned 12,299,207 shares of the company's stock, valued at $15,742,984.96. The trade was a -1,674.30% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 10.20% of the stock is owned by company insiders.

Institutional Investors Weigh In On Rafael

Several institutional investors have recently modified their holdings of RFL. Marshall Wace LLP acquired a new stake in shares of Rafael in the second quarter valued at approximately $50,000. Geode Capital Management LLC grew its stake in Rafael by 72.9% during the second quarter. Geode Capital Management LLC now owns 451,139 shares of the company's stock worth $781,000 after buying an additional 190,179 shares in the last quarter. Americana Partners LLC acquired a new stake in Rafael during the second quarter worth about $76,000. Simplex Trading LLC bought a new position in shares of Rafael in the second quarter worth about $32,000. Finally, Ieq Capital LLC bought a new position in shares of Rafael in the first quarter worth about $447,000. Institutional investors and hedge funds own 11.30% of the company's stock.

About Rafael

(Get Free Report)

Rafael Holdings, Inc primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.

Read More

Should You Invest $1,000 in Rafael Right Now?

Before you consider Rafael, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rafael wasn't on the list.

While Rafael currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover
7 Stocks to Ride The A.I. Megaboom


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.